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PATTERNS & PHENOTYPES
Genetic Targeting of the Endoderm With
Claudin-6
CreER
William J. Anderson, Qiao Zhou, Victor Alcalde, Osamu F. Kaneko, Leah J. Blank,
Richard I. Sherwood, J. Sawalla Guseh, Jayaraj Rajagopal, and Douglas A. Melton*
A full description of the ontogeny of the  cell would guide efforts to generate  cells from embryonic stem
cells (ESCs). The ﬁrst step requires an understanding of deﬁnitive endoderm: the genes and signals
responsible for its speciﬁcation, proliferation, and patterning. This report describes a global marker of
deﬁnitive endoderm, Claudin-6 (Cldn6). We report its expression in early development with particular
attention to deﬁnitive endoderm derivatives. To create a genetic system to drive gene expression
throughout the deﬁnitive endoderm with both spatial and temporal control, we target the endogenous locus
with an inducible Cre recombinase (Cre-ER
T2) cassette. Cldn6 null mice are viable and fertile with no
obvious phenotypic abnormalities. We also report a lineage analysis of the fate of Cldn6-expressing
embryonic cells, which is relevant to the development of the pancreas, lung, and liver. Developmental
Dynamics 237:504–512, 2008. © 2008 Wiley-Liss, Inc.
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INTRODUCTION
During gastrulation, pluripotent cells of
the epiblast become speciﬁed to form
one of the three embryonic germ layers:
ectoderm, mesoderm, or deﬁnitive
endoderm. The deﬁnitive endoderm
gives rise to the epithelia of numerous
organs including the thyroid, lung,
liver, stomach, pancreas, and intes-
tines. In the past decade, the potential
use of embryonic stem cells (ESCs) as
cell based therapeutic vehicles to treat
diseases has been amply discussed.
Current investigations are underway in
numerous laboratories to elucidate
paracrine factors that can direct differ-
entiation of ESCs to deﬁnitive
endoderm, which can then be further
instructed to differentiate into an organ
progenitor cell, and ultimately to a fully
differentiated cell type of interest (such
as hepatocytes of the liver, epithelial
cells of the lung, or  cells of the pan-
creas).
This presents the challenge of un-
derstanding how deﬁnitive endoderm
is formed and patterned. Speciﬁcation
of deﬁnitive endoderm is a Nodal-de-
pendent process (Schier, 2003) but lit-
tle is known about endoderm progen-
itor cells; the cues responsible for
their expansion and the signals that
pattern the gut tube along the anteri-
or-posterior axis are yet unknown.
Tools that would enable the ge-
netic manipulation of the deﬁnitive
endoderm will help to better under-
stand these processes. To that end,
we have sought a marker that would
target deﬁnitive endoderm during
development. A promising candidate
arose from an in situ hybridization
screen performed by Rosa Bedding-
ton’s group (Sousa-Nunes et al.,
2003). They examined expression of
genes from an E7.5 endoderm cDNA
library, which was derived from vis-
ceral and deﬁnitive endoderm, and
the node-tissues responsible for
speciﬁcation of the axial mesend-
oderm. One clone, r8707a53, was ex-
pressed in the forebrain, visceral
yolk sac, otic vesicle, and throughout
the entire deﬁnitive endoderm at
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© 2008 Wiley-Liss, Inc.E9.0. This clone encoded a member
of the Claudin superfamily of pro-
teins, Claudin-6.
Claudins are the major structural
proteins involved in tight junction for-
mation. Currently in the mouse, there
are 24 genes in the Claudin superfam-
ily. Based on expression patterns, it is
possible that Claudins come in two va-
rieties: “housekeeping” Claudins and
tissue-speciﬁc Claudins (Van Itallie
and Anderson, 2006).
Cldn6 was ﬁrst identiﬁed by search-
ing for sequences in genomic data-
bases that were similar to Cldn1 and
Cldn2. It was isolated by PCR from
mouse kidney and found to encode a
protein of 219 amino acids in length
with a molecular mass of 23.4 kDa
(Morita et al., 1999). Cldn6 has been
subsequently studied both in vitro and
in vivo (Turksen and Troy, 2001;
Turksen and Troy, 2002; Troy et al.,
2005; Arabzadeh et al., 2006). While
its functional role in the epidermal
permeability barrier is of importance,
our interest in Cldn6 is as a marker of
endoderm and a means to manipulate
gene expression therein.
RESULTS AND DISCUSSION
Expression of Claudin-6, a
Global Marker of Deﬁnitive
Endoderm
We examined expression of Cldn6 by
in situ hybridization, in sections and
whole mounts, from gastrulation to
the initial stages of organogenesis
(Fig. 1). At E6.5, Cldn6 is broadly ex-
pressed throughout the epiblast as
well as the hypoblast. It is absent in
the primitive streak (Fig. 1A) and in
some visceral endoderm surrounding
the epiblast (Fig. 1A,D). This lack of
expression in the primitive streak is
not surprising, as cells undergo an ep-
ithelial-to-mesenchymal transition
(EMT) as they migrate to form meso-
derm and deﬁnitive endoderm, thus
dissolving adherens and tight junc-
tions (Solursh and Revel, 1978; Tam
et al., 1993; Cano et al., 2000; Batlle et
al., 2000; Zohn et al., 2006; Ikenouchi
et al., 2003; Ohkubo and Ozawa,
2004). At E7.5, expression is still evi-
dent throughout most of the epiblast
(Fig. 1B,E). The primitive streak and
nascent mesoderm are devoid of
Cldn6 expression (Fig. 1E). By E8.5,
expression begins to become restricted
to the deﬁnitive endoderm (Fig. 1C,F).
This is the stage when initial pattern-
ing of the gut tube along the anterior-
posterior axis is thought to occur. At
E9.5, intense expression is seen in the
entire gut, otic vesicles, and a small
region of the forebrain (Fig. 1G). This
expression pattern at E9.5 is compa-
rable to what is reported by others
(Gitton et al., 2002; Sousa-Nunes et
al., 2003). At E10.5, expression is sim-
ilar to E9.5, but staining in the meso-
nephros and forebrain is now more ap-
parent (Fig. 1H).
To examine whether Cldn6 main-
tains epithelial expression in
endoderm-derived organs, we per-
formed whole mount and section in
situ hybridization on embryonic lung
and pancreas. Cldn6 is strongly ex-
pressed in the epithelia of both organs
(Fig. 2A–F, 2G–H, pancreas). On sec-
tions, no staining in the mesenchyme
is evident (Fig. 2E,F,H).
To summarize, Cldn6 is expressed
broadly at early stages of development.
However, by E9.5, expression of Cldn6
is largely restricted to deﬁnitive
endoderm along its entire length, mak-
Fig. 1. Expression of Cldn6 from commencement of gastrulation to the early stages of gut tube
organogenesis. A,D: Expression at E6.5 is quite broad throughout the epiblast, with the exception
of the primitive streak and visceral endoderm. Similar expression is seen at E7.5 (B,E). C,F: By E8.5,
expression begins to be restricted to the endoderm and by E9.5 (G) and E10.5 (H), expression is
restricted to the endoderm, otic vesicle (arrowhead), and mesonephros (arrow). A–C are represen-
tative whole mount stainings for the sections in D–F), respectively. Embryos in D–F were sectioned
in their deciduas. Plane of section is indicated by a line in the corresponding whole mount embryo.
For E, posterior is facing up. dec, decidua; ect, ectoderm; mes, mesoderm; end, endoderm; rm,
Reichert’s membrane; nf, neural fold; he, heart.
ENDODERM TARGETING IN MOUSE 505ing it a good candidate as a global
endoderm marker. Other markers that
have been used to mark endoderm in-
clude Shh, FoxA genes, and Sox17. Shh,
while initially expressed throughout
the deﬁnitive endoderm, is downregu-
lated in the prospective pancreatic re-
gion (Apelqvist et al., 1997). Of the
FoxA genes, FoxA3 is not expressed in
the most anterior endoderm deriva-
tives, while FoxA1 and FoxA2 are ex-
pressed throughout the deﬁnitive
endoderm as well as other tissues such
as the notochord and neural tube (Mon-
aghan et al., 1993). Sox17, while ex-
pressed in nascent endoderm, is down-
regulated in the endoderm at stages
post E7.5 and is expressed in other tis-
sues such as vasculature (Kanai-Azuma
et al., 2002; Matsui et al., 2006; unpub-
lished observations). This makes Cldn6
one of the few genes that allows for tar-
geting of the deﬁnitive endoderm
throughout the entire anterior-poste-
rior axis before and after gut tube pat-
terning (E8.0 onward).
Expression of Cldn6 in the
Adult Mouse
We investigated whether Cldn6 was
expressed in epithelial structures in
the adult. Adult mice of both sexes
were sacriﬁced and organs were har-
vested and transcriptional analysis
was performed by RT-PCR. Out of the
23 tissues examined, Cldn6 was
present in 11 tissues (see Supplemen-
tal Fig. 1, which can be viewed at ww-
w.interscience.wiley.com/jpages/1058-
8388/suppmat). Using -actin as a
loading control, we can make a semi-
quantitative assessment of relative
expression levels. Cldn6 is most
highly expressed in the olfactory epi-
thelium, followed by the coagulating
gland, kidney, eye, trachea, prostate,
epididymis, lung, liver, eye gland, and
uterine horns. Immunohistochemistry
with goat anti-Cldn6 polyclonal anti-
bodies, however, failed to detect Cldn6
in lung, trachea, kidney, or testis
(data not shown). These results are in
broad agreement with previous re-
ports that Cldn6 expression in the
adult is very weak or absent (Morita
et al., 1999; Turksen and Troy,
2004).
Generation of the Cldn6
CIHV
Allele
Based on its expression during early
development, we hypothesized that
the Cldn6 gene would be useful to
drive expression throughout the en-
tire endoderm. One genetic method
that has been used extensively for
gain of function or loss of function
studies is the Cre-ER system (Branda
and Dymecki, 2004). Applications of
this system can include activation or
removal of target genes in a spatially
and temporally controlled manner.
A multifunctional cassette was gen-
erated consisting of the Cre-ER
T2 gene
for genetic manipulation, followed by
an internal ribosome entry site
(IRES), the gene encoding a nuclear
localized yellow ﬂuorescent protein
variant (the histone 2B/Venus fusion)
as a reporter for gene expression, a
strong transcriptional stop sequence
using the SV40 polyadenylation sig-
nal to prevent transcriptional read-
through, and a ﬂoxed selection cas-
sette that self-excises in the male
germline. We termed this cassette
“CIHV” for Cre-ER
T2-IRES-H2B/Ve-
nus (Zhou et al., 2007).
We ﬁrst tested this construct by
transfection into COS cells. A plasmid
was made with the CIHV cassette
cloned downstream from a CAGGS
promoter. As shown in Supplemental
Figure 2, all transfected cells express
a nuclear localized YFP. To test
whether Cre recombinase activity is
tamoxifen-dependent, we co-trans-
fected a plasmid with a CAGGS pro-
moter upstream of a ﬂoxed transcrip-
tional stop and cytoplasmic RFP. RFP
expression was dependent upon addi-
tion of 4-hydroxytamoxifen to the cul-
ture media, verifying that the Cre-
ER
T2 system is tightly regulated (see
Suppl. Fig. 2).
AV3 mouse ES cells (a gift from Jill
McMahon) were targeted with the
CIHV cassette (Suppl. Fig. 3). Out of a
total of 1,474 colonies screened, one
clone (E40) successfully underwent
homologous recombination at the
Cldn6 locus (Fig. 3A,B). Chimeras
were generated by blastocyst injection
and transmitted the allele through
the germline (Fig. 3B). Heterozygotes
from this cross were renamed
Cldn6
CIHV/.
A Genetic Lineage Analysis
of Cldn6
 Cells at Different
Time Points in Development
To test Cre activity, we crossed
Cldn6
CIHV/ males to homozygous
ROSA26 Reporter (R26R) females
(Suppl. Fig. 4A). The R26R line has a
ﬂoxed transcriptional stop sequence
followed by the neomycin resistance/
lacZ fusion gene geo inserted into the
ROSA26 locus, a non-coding open
reading frame in the mouse that is
ubiquitously expressed in all tissues
(Soriano, 1999). This cross permits in-
delible labeling of cells that express
Cldn6 at the time of tamoxifen injec-
tion and all of their progeny.
We experimented with tamoxifen
dosage as was done previously (Ha-
yashi and McMahon, 2002) and found
that a 4-mg injection of tamoxifen to
pregnant females provided maximum
labeling of embryos without signiﬁ-
cant embryonic loss (between 0–2 em-
bryos resorbed per litter). We then
performed a time course of tamoxifen
injection during embryonic develop-
ment, which is schematized in Supple-
mental Figure 4B. Four milligram ta-
moxifen injections were administered
to pregnant females between E5.5 and
E12.5, with embryos whose mothers
were injected between E5.5 and
E10.5, harvested on E12.5, and those
whose mothers were injected on E11.5
and E12.5, harvested on E15.5. Se-
lected whole mount images are shown
in Figure 4. At all stages examined,
neither Cre-independent -galactosi-
dase expression nor tamoxifen-inde-
pendent -galactosidase expression
was detected (data not shown). Em-
bryos at each stage of injection were
sectioned post-staining to better visu-
alize localization of the signal to the
epithelial or mesenchymal compart-
ments (data not shown).
Tamoxifen injection to pregnant fe-
males at E5.5 labels cells throughout
the embryo, both in the epithelia and
mesenchyme (Figs. 4A–C, 5A). This is
consistent with the ubiquitous expres-
sion of Cldn6 at the time Cre recom-
binase would be most active (roughly
E6.0–7.0). Based on the composite
data, it appears E7.5 is the best time
point for tamoxifen administration
(Fig. 4D–F) if one aims to mostly label
deﬁnitive endoderm and its deriva-
tives without ubiquitous labeling of
506 ANDERSON ET AL.the embryo. From this stage forward,
Cre-mediated recombination is de-
tected in epithelia including all
endoderm-derived organs (Figs.
4D,E,G–J, 5C,F), the kidney (Figs.
4G,K, 5G,H), olfactory epithelia, lens
epithelia, and semicircular canal
(data not shown). Cells that appear to
be melanocytes also label (Fig.
4C,F,L), although Cldn6 expression in
these cells is too low to visualize by in
situ hybridization. Based on the kinet-
ics of tamoxifen, E7.5 would be the
optimal stage for misexpression in de-
ﬁnitive endoderm as Cre recombinase
would be active around the time the
endoderm is patterned and before or-
Fig. 2.
Fig. 3.
Fig. 2. Epithelial-restricted expression of Cldn6 in
the developing lung and pancreas. A–D: Whole
mount in situ hybridization shows Cldn6 expres-
sion throughout the entire epithelia of the lung
from E11.5 to E14.5 [(A) E11.5, (B) E12.5, (C)
E13.5, (D) E14.5)]. E,F: Expression of Cldn6 in the
E14.5 lung is restricted to the epithelia with no
mesenchymal expression. E: Expression of Cldn6
can be seen in the tracheal epithelia, as well as
both the proximal and distal airways. F: A higher
magniﬁcation view of staining from a different
lung. Epithelia is outlined by a black dashed line.
G: Expression of Cldn6 in the E14.5 pancreas. As
with the lung, expression is restricted to the epi-
thelia. Staining in the epithelial lining of the stom-
ach can be seen faintly. H: Cldn6 expression in
the E13.5 pancreas. The pancreas is still attached
to the stomach. Strong epithelial staining can be
seen in the branching epithelia. panc, pancreas;
st, stomach.
Fig. 3. Successful targeting of the Cldn6 locus
with the CIHV cassette. A: Southern blot anal-
ysis. Upon successful recombination, the en-
tire coding sequence for Cldn6 is removed,
generating a null allele. After NcoI digest, the
wild type locus generates a band of approx-
imately 12.5 kb, while the targeted allele has a
smaller band close to 8 kb. For reference, the
ﬁrst two bands on the 1-kb ladder are 10 and
8 kb, respectively. As seen in the parental ES
cell lane (AV3), only one band is present
higher than 10 kb, while in the targeted ES
cell clone lane (E40), there is a band at the
same height as in the wild type lane, but a
second band present at 8 kb. B: Genotyping
by PCR conﬁrms germline transmission of the
CIHV allele. AV3 and E40 refer to the parental
ES cell line and targeted ES cell line used for
blastocyst injection, respectively. The upper
gel distinguishes between the wild type and
targeted locus. The lower gel is a PCR to
demonstrate ACN cassette removal during
germline transmission. C,D: Cldn6
CIHV/CIHV
mice are null mutants for Cldn6. In situ hy-
bridization for Cldn6 in embryos from a
Cldn6
CIHV/ intercross. C: Cldn6
CIHV/;D :
Cldn6
CIHV/CIHV. As shown in D, Cldn6 mRNA is
absent in the Cldn6
CIHV/CIHV embryo.
ENDODERM TARGETING IN MOUSE 507ganogenesis begins. Of note, given
that the degree of Cre-mediated re-
combination is dependent upon the
dose of tamoxifen administered, not
all Cldn6-expressing cells undergo re-
combination at the dose used here.
In summary, Cldn6 is expressed in
various epithelia in the developing em-
bryo. It is a more useful deﬁnitive
endoderm marker than others that
have been described to date including
the widely used marker Sox17. Using a
Fig. 4. Lineage analysis of Cldn6
 cells at different times in embryonic development. Tamoxifen injection at E5.5 shows widespread labeling throughout
the embryo (A–C). Tamoxifen injection at E7.5 and later shows epithelial-restricted expression of -galactosidase in deﬁnitive endoderm derivatives (D,E,
G–J). Epithelia of the kidney is also labeled (G, K). Melanocytes also label (C, F, scattered cells in L), with a decrease in labeling correlating to later times of
tamoxifen injection. Embryos administered tamoxifen at E5.5 (A–C) and E7.5 (D–F) were harvested at E12.5 for analysis. Embryos administered tamoxifen
at E11.5 (G–L) were harvested at E15.5 for analysis. panc, pancreas; lu, lung; liv, liver; st, stomach; kid, kidney; int, intestine.
508 ANDERSON ET AL.tamoxifen-inducible form of Cre recom-
binase, we are able to target the entire
endoderm using the Cldn6
CIHV line.
Based on the timing of tamoxifen ad-
ministration, one can target various ep-
ithelia in the developing embryo for
gain of function or loss of function stud-
ies. To our knowledge, this is the ﬁrst
and only Cre-ER line available to glo-
bally target the endoderm at stages
prior to patterning and during organo-
genesis without affecting most other tis-
sues.
The Cldn6
CIHV line has distinct ad-
vantages compared to other genetically
modiﬁed mice. While Shh
Cre-ER mice
(Harfe et al., 2004) can target deﬁnitive
endoderm, they cannot target pancre-
atic endoderm during initial stages of
organogenesis. As mentioned earlier,
FoxA3
Cre transgenic mice do not target
the most anterior deﬁnitive endoderm
(Monaghan et al., 1993; Lee et al.,
2005). A FoxA2
rtTA line was recently re-
ported (Frank et al., 2007). This will
prove to be quite useful for crosses with
tetracycline operator responder lines.
Of note, the authors preserved the
FoxA2 coding sequence, as FoxA2 is
haploinsufﬁcient (Ang and Rossant,
1994; Weinstein et al., 1994). Crossing
to Cre responder lines, however, will be
somewhat laborious as it involves
generation of a triple transgenic.
Sox17
Cre-ER mice have not been re-
ported, though they would not be useful
for endoderm targeting post-E7.5 due to
predominant vascular expression (Mat-
sui et al., 2006; unpublished observa-
tions).
Cldn6
CIHV/CIHV Mice Are
Viable and Exhibit No Overt
Phenotype
To examine whether Cldn6 plays a role
in gastrulation or gut tube morphogen-
esis, mice heterozygous for the Cldn6
allele (Cldn6
CIHV/) were mated. Fe-
male mice were allowed to give birth
and progeny were genotyped by tail
biopsy upon weaning. Homozygous
null mice (Cldn6
CIHV/CIHV) were re-
trieved in the expected Mendelian ra-
tio by PCR genotyping. These mice
show no obvious anatomical pheno-
typic abnormalities and responded to
sound (data not shown).
To ensure that targeting the Cldn6
locus with the CIHV cassette gener-
ated a complete null allele, mice het-
Fig. 5. Injection of tamoxifen post-E7.5 results in epithelial-speciﬁc expression of -galactosi-
dase. In all images, epithelia is outlined in black dashed lines. A–D: In the E15.5 lung, injection at
E5.5 (A) or E6.5 (B) labels mesenchymal cells, yet injections at E7.5 and later, shown here at E11.5
(C) or E12.5 (D), only label epithelia. Stage of harvesting: (A,B), E12.5; (C,D), E15.5. E,F: In the E12.5
pancreas, injection at E6.5 (E) leads to strong staining in the epithelia as well as in some scattered
mesenchyme. Injection at E7.5 (F) is restricted to the epithelia. No mesenchymal staining was seen
in any section examined. G,H: In the E15.5 kidney, injection at E11.5 (G) and E12.5 (H) are shown.
All magniﬁcation at 10 except F at 20. inj., injection.
ENDODERM TARGETING IN MOUSE 509erozygous for Cldn6 were again mated
and embryos were harvested at E9.5
for in situ hybridization. As seen in
Figure 3D, no Cldn6 mRNA was de-
tected in Cldn6
CIHV/CIHV embryos.
To investigate whether Cldn6 null
mice are able to mate normally,
Cldn6
CIHV/CIHV mice were mated and
allowed to give birth. Females gave
birth to litters of normal size. New-
borns looked healthy with no grossly
abnormal phenotype (data not
shown). Mothers showed no rejection
of the pups. Mothers nursed normally
and successfully exhibited pup re-
trieval behavior (data not shown).
This would suggest that pheromone
detection and olfactory cues, at least
with regards to mating and nursing
behaviors, are normal in these mice.
Concurrently, E8.5 embryos were
dissociated and embryonic germ lay-
ers were analyzed by microarray anal-
ysis (Sherwood et al., 2007). Upon ex-
amining the list for members of the
Claudin gene family, there are eight
different Claudins expressed in the
endoderm, with Cldn6 being the high-
est relative value (Table 1). The other
seven, in order of relative expression,
are Cldn7, Cldn12, Cldn8, Cldn4,
Cldn10, Cldn3, and Cldn11. While
this type of analysis does not provide
cellular resolution, it suggests that
other Claudin family members may
compensate for loss of Cldn6 in the
endoderm. Further analysis by in situ
hybridization and double loss of
function studies may shed insight
onto this mechanism. In addition,
Cldn6
CIHV/CIHV mice may have subtle
phenotypic abnormalities that will be
more difﬁcult to reveal or that may
appear more noticeable with age.
Role of Cldn6 in
Gastrulation and Endoderm
Development
Cldn6 null mice appear phenotypi-
cally normal based on anatomical cri-
teria and overt behavior. From mi-
croarray data, this is most likely due
to compensation by another Claudin
family member, with Cldn7 as a likely
candidate. This does not rule out a
possible role for Cldn6 in endoderm
development. Functional redundancy
has been shown in processes impor-
tant for gastrulation before. For exam-
ple, in the frog, Cer1 and Lefty1 both
play important roles in blocking BMP
and Nodal signaling. In mouse,
Cer1
/ mutants (Simpson et al.,
1999; Shawlot et al., 2000; Stanley et
al., 2000; Belo et al., 2000) and
Lefty1
/ (Meno et al., 1998) mutants
have no overt phenotype at gastrula-
tion. However, Cer1
/; Lefty1
/
double mutants develop multiple
primitive streaks due to Nodal expres-
sion expanding outside of the poste-
rior region of the embryo (Perea-Go-
mez et al., 2002). Therefore, a
Cldn6
/; Cldn7
/ mutant might
show a severe phenotype, and mani-
fest at gastrulation or perhaps even
earlier upon egg cylinder formation.
An application of this genetic sys-
tem is to target the endoderm for
misexpression studies. One means is
to use a gain-of-function approach,
crossing the Cldn6
CIHV line with dif-
ferent Cre responder lines that consti-
tutively activate different signaling
pathways upon removal of a ﬂoxed
stop cassette. The role of the Notch,
Hedgehog, and Wnt signaling path-
ways in Cldn6-positive cells would be
interesting to examine given that
many responder lines currently exist
(Murtaugh et al., 2003; Jeong et al.,
2004; Harada et al., 1999). Further
TABLE 1. Microarray Analysis of Claudin Gene Expression
a
Gene Accession ES cells Endoderm Ectoderm Mesoderm EE endoderm EE mesoderm
CLDN01 1437932_a_at 14 24 38 87 37 15
CLDN02 1417231_at 14 19 15 36 1481 126
CLDN03 1460569_x_at 22 41 16 13 29 17
CLDN04 1418283_at 12 70 8 6 12 7
CLDN05 1417839_at 16 12 15 51 28 111
CLDN06 1417845_at 1504 4606 598 58 6174 72
CLDN07 1448893_at 947 1951 118 23 3762 31
CLDN08 1449091_at 9 198 12 11 17 8
CLDN09 1450524_at 13 15 11 11 12 11
CLDN10 1426147_at 14 51 29 26 16 12
CLDN11 1416003_at 7 38 15 47 12 16
CLDN12 1433781_a_at 803 1564 1726 1634 1504 723
CLDN13 1422920_at 20 16 17 16 17 61
CLDN14 1420345_at 15 13 12 14 15 14
CLDN15 1418920_at 17 15 17 18 17 20
CLDN16 1420434_at 10 10 10 9 11 10
CLDN18 1449428_at 9 9 10 9 11 9
CLDN19 1425727_at 9 8 8 7 8 8
CLDN22 1430237_at 23 19 18 18 22 24
CLDN23 1424409_at 8 12 8 8 9 7
aExpression of different members of the Claudin family at E8.5. E8.5 embryos were dissociated and separated by embryonic lineage.
cDNA was isolated for each sample and hybridized to Affymetrix microarrays. Numbers reﬂect relative expression levels. Only
members of the Claudin family of genes are shown here. In the deﬁnitive endoderm, Cldn6 has the highest expression, followed by
Cldn 7, 12, 8, 4, 10, 3, and 11. Accession, accession number for gene in public NCBI database; endoderm, deﬁnitive endoderm; EE
endoderm, extraembryonic endoderm; EE mesoderm, extraembryonic mesoderm.
510 ANDERSON ET AL.analysis will be necessary to deter-
mine what role these different signal-
ing pathways play in the deﬁnitive
endoderm with regards to both organ
speciﬁcation and regulation of
endoderm progenitor cells. The
Cldn6
CIHV line, combined with the re-
cently reported FoxA2
rtTA line (Frank
et al., 2007), will prove to be useful
reagents in this regard. This under-
standing will lead to more efﬁcient
strategies to generate and expand de-
ﬁnitive endoderm from ESCs, as well
as subsequent differentiation to vari-
ous organ progenitor cells.
EXPERIMENTAL
PROCEDURES
In Situ Hybridization
In situ hybridization was performed
essentially as described using digoxi-
genin-labeled probes (Wilkinson,
1992). Tammy-Claire Troy (Ottawa
Health Research Institute) kindly pro-
vided the Cldn6 in situ plasmid.
RT-PCR
Organs were harvested from adult fe-
male and male ICR mice (Taconic) and
stored in RNAlater (Ambion) until
use. Total RNA was extracted with a
RNeasy Kit (Qiagen).
Generation of the CIHV
Cassette
We generated a construct consisting of
Cre-ER
T2, followed by an IRES ele-
ment, H2B-Venus, a strong transcrip-
tional stop, and a self-excising drug se-
lection cassette (ACN) (construct
referred to as CIHV). Pfx Taq polymer-
ase was used to generate 5 and 3 ho-
mology arms for Cldn6. PCR conditions
were as follows: 1 l AV3 (strain 129Sv)
genomic DNA, 10 l1 0  PCR buffer, 5
l Pfx enhancer, 1.5 l 10 mM dNTPs,
22 l 3M betaine, 1 l 50 mM MgSO4,
0.65 l DMSO, 1.5 l each of 10 M
forward and reverse primers, 5.35 l
dH2O, and 0.5 l Platinum Pfx poly-
merase (Invitrogen). Thermocycler con-
ditions were as follows: initial denatur-
ation at 94°C for 2 min, followed by 35
cycles of denaturation at 94°C for 10
sec, annealing at 55°C for 30 sec, and
extension at 68°C for 2 min plus 10 sec
per cycle, with a ﬁnal extension at 68°C
for 7 min. Fragments were TOPO
cloned into the pCRII vector (Invitro-
gen) and conﬁrmed by DNA sequencing
(MCB Sequencing Facility). Both arms
were subsequently ligated with the
CIHV cassette.
Targeting the Cldn6 Locus
With the CIHV Cassette
C6-CIHV vector was linearized and
phenol:chloroform extracted. AV3
mouse ES cells (7  10
6 cells/ml; a
kind gift from Jill McMahon) in Em-
bryoMax qualiﬁed electroporation
buffer (Specialty Media) were electro-
porated with 40 g of DNA and se-
lected with 300 g/ml Gentacin (In-
vitrogen) for 8–9 days. Roughly 1,000
colonies were picked and subjected to
Southern blot with a 995-bp 5 probe
(Sambrook et al., 1989). Correctly tar-
geted colonies were identiﬁed (E40).
The E40 ES cells were used for blas-
tocyst injection (Genome Manipula-
tion Facility). Eighteen chimeras were
born, 11 of which were high-grade chi-
meras. Three (males D1, D4, and E3)
transmitted through the germline
from crosses with C57Bl/6J females
(Jackson Laboratories).
All animal experiments described in
this report have been approved by the
Harvard University Institutional An-
imal Care and Use Committee.
PCR Genotyping
Genomic DNA isolation from tail bi-
opsy was performed following stan-
dard protocols (Laird et al., 1991). Off-
spring were genotyped by PCR using
the following strategy. The allele was
genotyped using a forward primer lo-
cated at the end of the 5 homology
arm (gtCldn6F) with two reverse
primers, one located in the Cre coding
sequence (Cre-R) and the other lo-
cated in the middle of the endogenous
Cldn6 coding sequence (gtCldn6R1). If
the locus was undisrupted, gtCldn6F
and gtCldn6R1 would amplify a
294-bp product. If the locus was tar-
geted with the CIHV cassette, the
product would be slightly less than
200 bp. To ensure self-excision of the
selection cassette, a PCR strategy was
designed to check for the presence of
the ACN cassette. Two forward prim-
ers, one in the Venus coding sequence
and the other in the ACN cassette it-
self were combined with a reverse
primer, gtCldn6R2, located in the 3
homology arm. If the ACN cassette
was still present, ACN-F and
gtCldn6R2 would produce 200-bp
fragment, while if the ACN cassette
was excised, the Venus-F and
gtCldn6R2 would produce 600-bp
fragment. In all cases, there was suc-
cessful ACN excision through the
male germline. Sequences for the
primers used are: ACN-F: 5–ATC
GCC TTC TAT CGC CTT CTT GAC
GAG TTC–3; Cre-R: 5–CGG ACA
GAA GCA TTT TCC AGG TAT GCT
CAG–3; gtCldn6F: 5–CAC TAC ACA
GCC CCC TCA AC–3; gtCldn6R1: 5–
TGA GGA GGG TGA CAA CAC AG–
3; gtCldn6R2: 5–GAG GTG GAG
CTT GGA CTC AG–3; Venus-F: 5–
ATC ACT CTC GGC ATG GAC GAG
CTG TAC AAG–3.
Tamoxifen Administration
Tamoxifen (Sigma) was dissolved in
corn oil (Sigma) at a concentration of
either 10 or 20 mg/ml and passed
through a 0.2-m ﬁlter. Injections
were administered to pregnant fe-
males intraperitoneally.
X-gal Staining of Cldn6
CIHV/;
ROSA26
Reporter/ Embryos
Timed pregnancies were collected, us-
ing E0.5 as the date of plug detection.
Embryos were dissected out of the de-
cidua, saving extraembryonic mem-
branes. To ensure penetration, heads
were removed and the body was evis-
cerated. The tissues were ﬁxed in 4%
paraformaldehyde in PBS for 1 hr at
4°C, followed by two PBS washes for
15 min each. -galactosidase staining
was performed using the HistoMark
X-gal Substrate Set (Kirkegaard &
Perry Laboratories). Incubations were
continued overnight at room tempera-
ture for maximal sensitivity.
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